Viewing Study NCT00244205


Ignite Creation Date: 2025-12-25 @ 3:18 AM
Ignite Modification Date: 2025-12-26 @ 1:57 AM
Study NCT ID: NCT00244205
Status: UNKNOWN
Last Update Posted: 2005-11-15
First Post: 2005-10-24
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Identifying Methylation Biomarkers for Monitoring Bladder Tumors
Sponsor: Copenhagen University Hospital at Herlev
Organization:

Study Overview

Official Title: Using PCR Technology (Polymerase Chain Reaction Technology) for Monitoring Patients With Bladder Tumors - Optimizing Genanalyses for Clinical Use.
Status: UNKNOWN
Status Verified Date: 2005-11
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: To investigate the methylation status of 4-6 genes in Urine and matching bladder tissue biopsies, in order to find methylation markers for use in a noninvasive test in monitoring patients with bladder tumors.
Detailed Description: None

Study Oversight

Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: